2574389-19-6
Chemical Structure
VD2173
- CAS No.: 2574389-19-6
- Formula:C31H45N9O6S
- Molecular Weight:671.81
IUPAC Name: (3S,6S,14S)-6-acetamido-N-((S)-1-(benzo[d]thiazol-2-yl)-5-guanidino-1-oxopentan-2-yl)-3-isobutyl-2,5,8-trioxo-1,4,9-triazacyclotetradecane-14-carboxamide
InChIKey: IWSNQHXPYYMOLJ-MLCQCVOFSA-N
SMILES: O=C1N[C@H](C(N[C@H](C(C2=NC3=CC=CC=C3S2)=O)CCCNC(N)=N)=O)CCCCNC(C[C@H](NC(C)=O)C(N[C@H]1CC(C)C)=O)=O
Biological Activity: VD2173 is a side chain cyclized macrocyclic peptide inhibitor of HGF-activating serine proteases. VD2173 potently inhibits matriptase and hepsin. VD2173 can be used for the research of lung cancer[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
VD2173 | VD2173 is a side chain cyclized macrocyclic peptide inhibitor of HGF-activating serine proteases. VD2173 potently inhibits matriptase and hepsin. VD2173 can be used for the research of lung cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
